Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mikhail Kosiborod, MD
Saint Luke's Mid America Heart Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heart Group of the Eastern Shore
Fairhope, Alabama, United States
- University of Southern Califiornia
Los Angeles, California, United States
- First Coast Cardiovascular Institute
Jacksonville, Florida, United States
- Charlotte Heart Group Research Center
Port Charlotte, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northshore University Healthsystem Research Institute
Evanston, Illinois, United States
- Northwestern University
Evanston, Illinois, United States
- Advocate Health and Hospitals
Oakbrook Terrace, Illinois, United States
- University of Maryland
Baltimore, Maryland, United States
- Walter Reed National Military Medical Center
Bethesda, Maryland, United States
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Freeman Health System
Joplin, Missouri, United States
- Saint Luke'S Hospital of Kansas City
Kansas City, Missouri, United States
- Truman Medical Center
Kansas City, Missouri, United States
- Washington University
St Louis, Missouri, United States
- New York University
New York, New York, United States
- St. Francis Hospital
Roslyn, New York, United States
- Duke University
Durham, North Carolina, United States
- Eastern Nephrology Associates
New Bern, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Mar 2016
- Primary completion
- 28 Jun 2019
- Completion
- 28 Jun 2019
- Last update posted
- 21 Apr 2022
- Registered enrollment
- 263
- Registry id
- NCT02653482
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.